FDA Inspection 1041321 — Robert Wood Johnson University Hospital Somerset
The FDA completed an inspection of Robert Wood Johnson University Hospital Somerset on February 12, 2018 in Somerville, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 12, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Somerville, NJ (United States)